- Type
- not stated
- Format
- Tabular — structured coded medical and prescription records with demographic and geographic fields, output as cohort lists plus funnel status tracking
- Volume
- Not printed. Order-of-magnitude estimate: a national commercial medical-plus-prescription network at this enterprise scale implies 10^10+ claim lines and a comparable volume of pharmacy dispense records annually, each longitudinally linked to the same member. Only the documented pilot is quantified: 6,700 contacted patients, 378 responders, 160 screening passes in one breast-cancer programme.
- Users
- N/A as registered users — this is an insured-population data asset, not an account-based product. The relevant population is the underlying commercial medical and prescription network, which the enterprise's scale (revenue range in the hundreds of billions, ~23,000 employees) implies is order tens of millions to 100M+ covered lives. Exact count is not printed on the source; confirm the licensable population with the data team.
- History
- 20 years
- Update frequency
- not stated
- Growth
- Active — a named Clinical Trial Solutions product line with a dedicated programme mailbox, current-dated (2024) client case studies, an explicit stated mission to broaden clinical-research inclusion, and a densely staffed data organisation (multiple VP and Director roles across analytics, engineering, management and governance) all indicating active build-out of the recruitment offering.
- Launched
- About 2022-2023 for the Evernorth brand and this named Clinical Trial Solutions offering (the corporate brand is a recent consolidation of the health-services businesses; the case-study collateral is hosted as a 2024 file). The underlying medical and prescription data assets are far older, accumulated through two decades of benefits and pharmacy-benefit acquisitions.
- Delivery
- not stated
- Entity mapping
- not stated
- Sample
- not stated
- Point-in-time
- not stated
- Licence
- not stated